Nástroje

iconicon Akciový screener
iconicon Kalendář zisků
iconicon Super investoři

Ostatní

iconicon Návod
IČ: 19940963

5. května 521, 501 01 Turnov
Zásady GDPR
Podmínky služby
Všechna práva vyhrazena @ 2024, Fundamenty.cz
Proudly created by draftspot.net
ImmunityBio, Inc.
ImmunityBio, Inc.
IBRX
Valuace
100
Růst
60
Zdraví
50
Cena
$ 2.15
Dnes
+1.57 (39.75%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
2.0B
Obrat
0B
Zisk
0B
Aktiva
0B
Dluh
0B
ROE
0%
ROA
0%
PE
-24
PS
74
Cena 1R
2-6
⌀ Cena
2.52
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
02-03-2026
Poslední dividenda

Profil

ImmunityBio, Inc., společnost zabývající se biotechnologií v klinickém stadiu, vyvíjí terapie a vakcíny pro léčbu rakoviny a infekčních onemocnění. Nabízí imunoterapii a platformy buněčné terapie, včetně protilátkových proteinů sloučených cytokinů, syntetických imunomodulátorů, vakcinačních technologií, přirozených zabijáckých buněk a adaptivního imunitního systému (T buněk). Společnost také vyvíjí terapeutické látky, které jsou v klinických studiích fáze II nebo III pro léčbu tekutých a solidních nádorů, včetně rakoviny močového měchýře, slinivky břišní a plic, stejně jako patogeny jako SARS-CoV- 2 a HIV. Má dohody o spolupráci s National Cancer Institute, National Institute of Deafness and Communication Disorders a Amyris, Inc.; a licenční dohody s CytRx Corporation, EnGeneIC Pty Limited, GlobeImmune, Inc., and Infectious Disease Research Institute, Sanford Health, Shenzhen Beike Biotechnology Co. Ltd., Sorrento Therapeutics, Inc. a Viracta Therapeutics, Inc. Společnost byla založena v roce 2014 a sídlí v San Diegu v Kalifornii.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
671
Založení
2015-07-28
Adresa
3530 John Hopkins Court
CEO
Richard Gerald Adcock
Web
immunitybio.com

Podobné společnosti

RCUS
Arcus Biosciences, Inc.
$ 19.95
+ $ 0.64
DNLI
Denali Therapeutics Inc.
$ 16.13
+ $ 1.11
ETNB
89bio, Inc.
$ 14.84
+ $ 0.00
COGT
Cogent Biosciences, Inc.
$ 33.20
+ $ 18.38
GLPG
Galapagos N.V.
$ 32.15
+ $ 0.62
BEAM
Beam Therapeutics Inc.
$ 21.90
- $ 0.31
RXRX
Recursion Pharmaceuticals, Inc.
$ 4.52
- $ 0.10

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 202520242023202220212020201920182017201620152014
Total Revenues113.3113.314.70.60.20.90.62.20.00.00.00.20.6
Cost of Revenues8.60.80.00.00.00.00.00.00.00.00.00.00.0
Gross Profit104.7112.514.70.60.20.90.62.20.00.00.00.20.6
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues38.332.126.416.57.66.11.00.00.10.1
Cost of Revenues4.24.10.10.10.00.00.00.04.64.6
Gross Profit34.027.926.316.57.66.11.00.0-4.4-4.5
Operating Income TTM 202520242023202220212020201920182017201620152014
R&D Expenses0.00.00.0232.4248.1196.0139.5112.055.742.029.211.41.6
Selling General & Admin Expenses0.00.00.0129.6102.7135.371.346.542.757.195.4227.74.3
Depreciation & Amortization15.515.517.618.57.314.025.816.39.65.63.61.50.1
Total Operating Expenses360.7368.6358.9362.9350.9331.2210.8158.598.499.2124.5239.15.9
Operating Income-256.0-256.0-344.2-362.3-351.3-330.3-220.9-156.3-96.3-96.3-121.3-237.2-6.2
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.051.048.4
Selling General & Admin Expenses0.00.00.00.00.00.00.00.029.031.8
Depreciation & Amortization3.94.03.93.84.24.44.44.64.64.6
Total Operating Expenses98.783.697.680.977.086.4100.495.280.180.2
Operating Income-64.7-55.6-71.3-64.4-69.4-80.3-99.3-95.2-84.5-80.1
Net Income TTM 202520242023202220212020201920182017201620152014
Interest Income6.76.72.40.92.70.81.72.80.00.00.00.00.0
Interest Expense112.5112.5131.7129.263.514.89.15.90.40.60.10.00.0
Other Expense-95.6-95.6-69.5-221.6-66.0-19.6-5.2-4.0-0.4-0.6-0.11.70.0
IBT-351.6-351.6-413.6-583.9-417.3-349.8-226.0-160.3-96.7-96.9-121.4-237.2-6.2
Income Tax Expense-0.1-0.10.00.00.00.0-1.8-0.1-0.5-0.5-0.6-0.30.0
Net Income-351.4-351.4-413.6-583.2-417.3-349.8-224.2-160.2-96.2-96.4-120.8-236.9-6.2
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income3.32.10.80.50.80.60.82.41.80.0
Interest Expense27.227.628.928.914.940.239.037.532.135.0
Other Expense2.6-11.7-21.0-65.510.2-5.5-35.3-38.9-149.0-15.5
IBT-62.1-67.3-92.3-129.9-59.2-85.8-134.6-134.1-233.5-95.6
Income Tax Expense-0.10.00.3-0.20.00.00.00.00.0-4.6
Net Income-61.9-67.3-92.6-129.6-59.2-85.7-134.6-134.1-233.4-95.6
Per Share Data TTM 202520242023202220212020201920182017201620152014
EPS$0.00$0.00$0.00$-1.15$-1.04$-0.90$-0.59$-0.42$-1.22$-1.20$-1.47$-3.31$-0.08
EPS Diluted$0.00$0.00$0.00$-1.15$-1.04$-0.90$-0.59$-0.42$-1.22$-1.20$-1.47$-3.31$-0.08
Shares Outstanding989.7919.9697.3508.6399.9389.2383.2383.279.180.682.071.578.9
Diluted Shares Outstanding989.7919.9700.4508.6399.9389.2383.2383.279.180.682.071.578.9
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.35$-0.19
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$-0.35$-0.19
Shares Outstanding989.7946.6888.2853.2733.2695.9686.9672.8670.9498.4
Diluted Shares Outstanding989.7946.6888.2853.2734.5698.0686.9672.8670.9498.4
Current Assets TTM 202420232022202120202019201820172016201520142013
Cash And Equivalents130.1143.4265.5104.6181.134.915.516.823.98.1175.959.10.4
Short Term Investments87.96.41.02.5136.061.136.157.3104.3190.8118.30.00.0
Total Cash & ST Investments218.0149.8266.5107.2317.196.151.774.1128.2198.9294.259.10.4
Accounts Receivable2.12.73.21.91.32.00.312.21.32.71.80.10.4
Inventory1.88.30.026.40.00.00.00.00.00.00.00.00.0
Other Current Assets21.023.924.55.115.913.63.82.53.03.61.50.10.2
Total Current Assets242.8184.6294.1140.6334.3111.755.888.8132.5205.1297.559.41.0
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents0.0137.760.7143.4112.0130.1133.0265.5178.043.5
Short Term Investments0.016.00.96.418.487.937.51.011.82.4
Total Cash & ST Investments153.7153.761.6149.8130.4218.0170.5266.5189.846.0
Accounts Receivable0.022.317.52.74.92.12.13.22.33.3
Inventory0.06.68.48.32.01.80.00.016.213.0
Other Current Assets-153.725.521.723.925.921.023.124.523.017.6
Total Current Assets0.0208.1109.2184.6163.2242.8195.7294.1215.166.8
Long-Term Assets TTM 202420232022202120202019201820172016201520142013
Net Property, Plant & Equipment175.8170.5182.7189.4119.290.772.276.976.719.36.10.20.0
Goodwill0.00.00.00.00.00.00.00.00.00.00.00.00.0
Intangible Assets16.115.917.120.01.41.50.00.62.85.17.30.80.9
Long-Term Investments7.00.00.95.76.810.49.38.50.00.00.00.00.0
Other Long-Term Assets2.612.09.76.67.27.15.915.738.488.055.90.40.2
Total Long-Term Assets201.5198.3210.4221.8134.6109.787.493.2118.0112.469.31.51.1
Total Assets444.3382.9504.5362.4468.9221.4143.1182.0250.4317.5366.860.82.1
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment0.0167.7167.1170.5174.2175.8178.7182.7187.8194.0
Goodwill0.00.90.90.00.90.00.00.00.00.0
Intangible Assets0.014.114.515.915.616.116.617.118.519.0
Long-Term Investments0.00.00.00.00.00.00.08.10.80.8
Other Long-Term Assets0.011.212.112.010.79.79.72.53.43.8
Total Long-Term Assets0.0193.9194.6198.3201.4201.5205.0210.4217.3224.4
Total Assets0.0402.1303.8382.9364.6444.3400.7504.5432.4291.2
Current Liabilities TTM 202420232022202120202019201820172016201520142013
Accounts Payable20.36.79.221.011.411.51.72.85.94.02.11.11.5
Short-Term Debt6.37.55.3434.6302.25.00.00.0-0.2-0.2-0.20.31.8
Other Current Liabilities35.440.843.845.355.351.69.824.515.08.54.10.51.2
Current Liabilities62.154.958.3500.9369.068.111.627.320.912.66.12.45.0
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable0.07.413.56.79.920.313.99.219.825.5
Short-Term Debt0.07.47.57.57.06.26.15.24.4524.5
Other Current Liabilities0.035.828.240.844.035.533.843.866.163.5
Current Liabilities0.050.649.254.961.062.153.858.390.3613.5
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013
Long-Term Debt956.3496.7721.5289.2343.4270.510.90.05.22.92.50.00.0
Capital Leases36.442.345.250.640.121.210.90.00.00.02.50.00.0
Def. Tax Liability0.00.00.00.00.20.20.00.00.51.01.20.00.0
Total Liabilities1,141.7871.11,090.4812.2712.8339.922.435.931.624.110.92.45.0
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt0.0527.9518.8496.7735.9729.3725.3721.5712.9294.7
Capital Leases0.043.240.642.343.842.744.339.943.750.5
Def. Tax Liability0.00.00.00.00.00.00.00.00.00.0
Total Liabilities569.8971.9894.2871.11,108.71,141.71,091.71,090.4843.1936.4
Total Common Equity TTM 202420232022202120202019201820172016201520142013
Common Stock0.10.10.10.00.00.00.00.00.00.00.00.00.0
Retained Earnings-3,230.4-3,375.2-2,961.7-2,378.5-1,961.9-1,615.1-662.2-595.0-498.7-387.1-250.4-12.7-6.5
Comprehensive Income0.01.20.00.20.00.1-18.6-11.6-4.3-1.2-0.20.00.0
Total Common Equity-698.4-489.1-587.0-447.3-242.2-119.8120.7146.0218.8293.4356.058.4-2.9
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock0.00.10.10.10.10.10.10.10.10.0
Retained Earnings0.0-3,597.4-3,504.9-3,375.2-3,316.1-3,230.4-3,095.8-2,961.7-2,728.3-2,632.7
Comprehensive Income-570.712.620.01.20.10.00.00.00.80.0
Total Common Equity-569.8-570.7-591.4-489.1-745.1-698.4-692.0-587.0-411.7-642.1
Other TTM 202420232022202120202019201820172016201520142013
Total Debt999.0504.2726.7723.8645.7275.514.86.97.38.22.50.31.8
Book Value-697.4-488.1-585.9-449.8-243.9-118.5120.7146.0218.8293.4356.058.4-2.9
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.90.91.01.01.01.01.11.1-3.1
Book Value-569.8-570.7-591.4-489.1-745.1-698.4-692.0-587.0-411.7-642.1
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013
Net Income-601.40.0-413.6-583.2-417.3-349.8-224.2-160.2-96.2-96.4-120.8-236.9-6.2-2.0
Depreciation & Amortization18.40.017.618.518.314.212.714.09.65.63.61.50.10.0
Stock-Based Compensation46.60.034.449.240.257.22.23.423.437.073.9211.20.80.9
Change Working Capital-27.6-54.3-19.44.0-8.0-19.116.4-15.6-50.1-81.0-98.8234.461.00.9
Change In Accounts Receivable0.0-40.2-2.40.00.00.00.00.00.00.0-1.50.10.1-0.2
Change In Accounts Payable-2.8-0.2-3.2-6.58.0-3.72.61.2-1.10.20.90.6-0.30.7
Change In Inventories0.0-6.3-8.30.00.00.00.00.00.00.00.00.00.00.0
Other Non-cash Items215.7-250.6-10.2144.829.423.124.16.250.586.6104.1-235.2-61.0-0.4
Cash from Operations-389.40.00.0-366.8-337.5-274.4-171.7-152.1-63.4-48.8-38.6-25.3-5.4-0.7
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income0.0-67.3-92.6-129.7-59.2-85.8-134.6-134.1-233.4-95.6
Depreciation & Amortization0.00.03.93.84.14.44.44.64.64.6
Stock-Based Compensation0.00.09.69.59.07.59.68.312.814.4
Change Working Capital-14.40.0-5.6-22.0-10.8-10.15.4-3.9-25.7-7.0
Change In Accounts Receivable-10.60.0-5.1-14.71.8-3.10.00.00.00.0
Change In Accounts Payable1.00.0-6.26.4-3.2-8.94.74.3-2.9-2.7
Change In Inventories-7.90.01.8-0.2-6.3-0.10.00.00.00.0
Other Non-cash Items-56.0-1.74.852.4-28.3-14.914.818.2151.39.9
Cash from Operations0.00.00.00.00.00.00.00.0-115.3-87.4
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013
Capital Expenditure-23.4-4.3-6.9-30.6-99.4-33.6-1.7-4.3-13.1-34.8-6.6-2.2-0.30.0
Acquisitions-10.20.0-1.00.0-1.00.00.00.20.00.0-0.10.00.00.0
Investments-58.6-241.4-140.2-10.4-34.3-141.8-91.8-87.2-95.5-119.9-273.0-198.10.00.0
Sales of Investment24.495.8136.610.5162.069.973.6112.3165.3254.2165.926.90.00.0
Other Investing Activities-34.20.00.00.00.020.50.0-2.50.40.00.1-1.80.00.0
Cash from Investing-57.60.00.0-30.527.3-84.9-19.818.657.199.6-113.7-175.2-0.30.0
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-1.30.0-1.1-1.1-2.1-2.8-0.7-1.3-8.0-5.7
Acquisitions0.00.00.00.00.00.00.00.0-10.20.0
Investments-45.60.0-15.1-0.1-6.1-0.7-85.8-48.4-0.2-10.0
Sales of Investment90.50.00.05.418.069.635.014.010.40.0
Other Investing Activities0.00.00.00.00.00.00.00.010.2-10.0
Cash from Investing0.00.00.00.00.00.00.00.02.2-15.6
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013
Debt Repaid-192.80.00.0258.6-0.10.00.00.0-0.5-19.90.0-0.1-0.10.0
Debt Issued322.0504.2-222.6261.678.2370.1260.77.90.119.05.82.3-1.41.8
Issuance of Common Stock76.90.00.0110.160.4164.586.330.00.00.00.0316.50.00.7
Repurchase of Common Stock-7.00.00.00.00.00.00.0-2.5-0.2-15.2-15.8-4.80.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Other Financing Activities610.60.00.0189.6173.2340.964.486.8-0.10.20.35.864.50.2
Cash from Financing491.70.00.0558.3233.6505.4150.7114.3-0.8-35.0-15.6317.364.40.9
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0192.7199.0
Debt Issued0.0-535.39.022.1-238.77.34.2-152.3359.297.1
Issuance of Common Stock0.00.00.00.00.00.00.00.09.440.0
Repurchase of Common Stock0.00.00.00.00.00.00.00.00.00.0
Dividends Paid0.00.00.00.00.00.00.00.00.00.0
Other Financing Activities0.00.00.00.00.00.00.00.0-1.6-1.4
Cash from Financing0.00.00.00.00.00.00.00.0200.5237.5
Cash position TTM 2025202420232022202120202019201820172016201520142013
Net Change in Cash44.6-54.5-121.9160.8-76.3146.2-40.9-19.3-7.115.8-167.8116.858.80.2
Closing Cash Balance133.089.4143.9265.5105.0181.335.176.017.023.98.1175.959.10.4
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash28.1-76.877.0-82.831.6-18.1-2.9-132.487.5134.5
Closing Cash Balance89.461.3137.761.1143.9112.3130.4133.4265.5178.3
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013
Free Cash Flow-412.8-308.8-398.1-397.3-436.9-308.0-173.4-156.4-76.5-83.6-45.2-27.5-5.7-0.7
Real Free Cash Flow-459.4-308.8-432.6-446.5-477.1-365.2-175.6-159.8-99.9-120.6-119.0-238.8-6.4-1.6
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow-71.2-68.9-80.8-87.0-87.3-101.6-101.1-108.2-123.2-93.1
Real Free Cash Flow-71.2-68.9-90.5-96.6-96.3-109.0-110.7-116.5-136.0-107.5
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-23.9-8.3-1.4
P/S744162.59.4
P/B-14.7-3.15.2
P/FCF-25.6-9-1.5
Market cap$2.0$10.3
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets0 %77.5 %0 %
Debt to Income0 %-66.6 %0 %
Debt to Free cash flow0 %-1148.3 %0 %
Interest expense percentage-44 %-8.8 %44.7 %
Current ratio0 7.8 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE61.7 %19.1 %0 %
ROA0 %-79.4 %0 %
CapEx to Revenue1.9 %16464.6 %0 %
RaD to Revenue0 %51714.6 %0 %
ROEM166,600.0 1003.5

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin99.3 %-251.1 %68.7 %
Operating margin-226 %-125310.3 %35.5 %
Net margin-310.2 %-131407.1 %9.5 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0 %0 %
Dividend payout percentage0 %-0.2 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding989.7 mil 327.5 mil
Employee count0.7 tis 0.3 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Získat přístup Kontaktujte nás
Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader